Search - tctmd.com

Displaying 101 - 120 of 161

Sort: Relevancy | Date

Presentation TCT 2013

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Presenter: Eugenia Nikolsky

October 31, 2013

Presentation TCT 2013

Antiplatelet Agent Conundrums: Potency, Resistance, Duration, and Single/Dual/Triple Therapy

Presenter: Matthew Price

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

Presentation TCT 2013

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Presenter: Eugenia Nikolsky

October 28, 2013

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

Presentation Scripps 2013

The Challenges of Triple Therapy: Managing the DES Patient Who Also Requires Anti-coagulation

Presenter: C. Michael Gibson

October 03, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Jason Kahn

September 27, 2013

News Daily News

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

Jason Kahn

September 27, 2013

Presentation

Comparison of Dual vs. Triple Antiplatelet Therapy After DES According to Stent Length

Presenter: S-W Lee

September 26, 2013

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

Late-Onset A-fib After MI Signals More Hospitalizations, Emergency Visits

August 30, 2013

News Daily News

La FA de Aparición Tardía tras un IM Sugiere Más Hospitalizaciones y Visitas a Emergencias

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

El FOP Aumenta el Riesgo de ACV tras la Implantación de los Electrodos del Dispositivo Endovascular

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

August 30, 2013

Advertisement

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Antiplatelet Agent Conundrums: Potency, Resistance, Duration, and Single/Dual/Triple Therapy

PCI vs. CABG a Close Call in Some Complex Patients

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

The Challenges of Triple Therapy: Managing the DES Patient Who Also Requires Anti-coagulation

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

Comparison of Dual vs. Triple Antiplatelet Therapy After DES According to Stent Length

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Late-Onset A-fib After MI Signals More Hospitalizations, Emergency Visits

La FA de Aparición Tardía tras un IM Sugiere Más Hospitalizaciones y Visitas a Emergencias

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

El FOP Aumenta el Riesgo de ACV tras la Implantación de los Electrodos del Dispositivo Endovascular

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content